Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

101416

registered interest
date	28/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will make an assessment of the effect of the National Institute for Health and Care Excellence's health technology appraisals on pancreatic cancer research.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	212353
answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>We have made no such assessment.</p><p> </p><p> </p><p> </p><p>The National Institute for Health Research is investing £6.5 million over five years to 2017 in the Liverpool Pancreas Biomedical Research Unit. This unit is working in partnership with industry and leading research institutions to develop new treatments and diagnostic strategies for pancreatic cancer, so advancements in science can lead to benefits for patients.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 03/11/2014 17:38:12 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

101420

registered interest
date	28/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Terminal Illnesses
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether health technology appraisal committees can apply the National Institute for Health and Care Excellence's end-of-life criteria flexibly when appraising treatments for patients with terminal illness.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	212351
answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>Appraisal Committees are independent advisory bodies responsible for making recommendations to the National Institute for Health and Care Excellence (NICE) on the clinical and cost effectiveness of treatments for use in the National Health Service.</p><p> </p><p> </p><p> </p><p>NICE’s <em>Guide to the Methods of Technology Appraisal</em> is published at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/article/PMG9/chapter/Foreword" target="_blank">www.nice.org.uk/article/PMG9/chapter/Foreword</a></p><p> </p><p> </p><p> </p><p>and describes how its Appraisal Committees reach decisions on treatments. It provides details of the criteria that need to be met in order to apply greater flexibility in the appraisal of life-extending drugs for patients at the end of their lives.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 03/11/2014 17:33:34 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

101421

registered interest
date	28/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many cancer drugs approved by the Cancer Drugs Fund have subsequently been (a) approved and (b) rejected by the National Institute for Health and Care Excellence.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	212352
answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>The National Institute for Health and Care Excellence (NICE) has published final technology appraisal guidance for 27 treatment indications that have been approved by the Cancer Drugs Fund panel for inclusion on its national list. Of these:</p><p> </p><p> </p><p> </p><p>- three treatment indications have been recommended by NICE;</p><p> </p><p>- three treatment indications have received an optimised recommendation from NICE, recommending use for to a smaller group of patients than is eligible for treatment through the Cancer Drugs Fund; and</p><p> </p><p>- 21 treatment indications have not been recommended. In some cases, NICE issued guidance that did not recommend a treatment before it was approved for inclusion the Cancer Drugs Fund national list.</p><p> </p><p> </p><p> </p><p>NICE is appraising but has yet to issue final guidance for some treatment indications. NICE is also currently updating its guidance for two treatment indications with an optimised recommendation; and one treatment indication that is not recommended. Additionally, a number of treatments on the Cancer Drugs Fund national list have not been appraised by NICE.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 03/11/2014 17:55:43 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

101423

registered interest
date	28/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Terminal Illnesses
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons the National Institute for Health and Care Excellence advises that end-of-life criteria should only apply to medicines that extend life by at least three months.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	212356
answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>I refer the hon. Member to my answer of 28 October 2014 to Question <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=211807" target="_blank">211807</a>.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 03/11/2014 17:31:01 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

101428

registered interest
date	28/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will assess the effect of the National Institute for Health and Care Excellence's three month end of life threshold on the appraisal of treatments for advanced pancreatic cancer.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	212326
answer	answer is ministerial correction date of answer 04/11/2014 answer text <p>I refer the hon. Member to my answer of 15 October 2014 to Question <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=209582" target="_blank">209582</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 04/11/2014 17:15:00 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

101431

registered interest
date	28/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will make an assessment of the National Institute for Health and Care Excellence's technology appraisal criteria in relation to the provision of new treatments for patients with pancreatic cancer.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	212359
answer	answer is ministerial correction date of answer 04/11/2014 answer text <p>We have made no such assessment. The National Institute for Health and Care Excellence is an independent body and is responsible for the development of its methods and processes, which it periodically updates in consultation with stakeholders.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 04/11/2014 17:22:16 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

101472

registered interest
date	28/10/2014
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Development Aid: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Development, what support her Department gives to (a) the European and Devoloping Countries Clinical Trials Partnership, (b) other innovative financing partnerships to develop new global health commodities for diseases of poverty including HIV/Aids and tuberculosis, (c) the TB Alliance, (d) the International Aids Vaccine Initiative and (e) other product development partnerships.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	212341
answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>The UK Medical Research Council (MRC) leads the UK Government relationship with the European and Developing Countries Clinical Trials Partnership (EDCTP). Over the period 2013-2018, DFID will provide £10 million to EDCTP through the MRC. In addition DFID support for product development research is counted as a Member State contribution to EDCTP.</p><p> </p><p> </p><p> </p><p>DFID contributes to a number of innovative product development partnerships (PDPs) for the development of drugs, vaccines, diagnostics and other technologies for diseases of poverty. Funding of £138 million for 2013-2018 was announced in August 2013 and includes support for the TB Alliance, the International AIDS vaccine Initiative and eight other PDPs (details of the awards were published in August 2013 and can be found at:</p><p> </p><p><a href="https://www.gov.uk/government/news/dfid-invests-to-save-millions-from-deadly-diseases" target="_blank">https://www.gov.uk/government/news/dfid-invests-to-save-millions-from-deadly-diseases</a>). In addition over the period 2012-2017, DFID will provide £6.5 million for the Saving Lives at Birth programme in partnership with the Bill and Melinda Gates Foundation, US Government, Norwegian Government and Grand Challenges Canada. This programme is supporting new technologies to prevent mothers and babies dying at birth.</p><p> </p> answering member constituency Hornsey and Wood Green answering member printed Lynne Featherstone question first answered 03/11/2014 16:29:26 answering member 1531 label Biography information for Baroness Featherstone
tabling member	4056 label Biography information for Nic Dakin

99801

registered interest
date	20/10/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	RAF Kirton in Lindsey
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, how much his Department spent on consultants engaged on the disposal of the Kirton-in-Lindsey airbase.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	211149
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The Department did not engage consultants to dispose of Kirton in Lindsey. <br><br>The airbase was disposed of by the Ministry of Defence, working with a marketing agent, in accordance with standard disposal procedures. Details of the marketing agent's costs cannot be released as to do so could prejudice commercial interests.</p> answering member constituency Broxtowe answering member printed Anna Soubry question first answered 27/10/2014 17:06:09 answering member 3938 label Biography information for Anna Soubry previous answer version 24027 answering member constituency Broxtowe answering member printed Anna Soubry answering member 3938 label Biography information for Anna Soubry
tabling member	4056 label Biography information for Nic Dakin

99859

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if his Department will commission a review of the innovation, evaluation and adoption of new medicines in the NHS; and if he will make a statement.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	211101
answer	answer is ministerial correction date of answer 23/10/2014 answer text <p>We are committed to ensuring National Health Service patients have access to effective medicines on terms that represent value to the NHS and taxpayers and that patients, are supported to get the best outcomes from their medicines.</p><p> </p><p> </p><p> </p><p>The Department, in collaboration with NHS England, has recently commissioned an independent evaluation of Innovation Health and Wealth. Jointly led by the University of Manchester and RAND Europe, The first initial phase is now underway, the study is expected to take three years to complete.</p><p> </p><p><em> </em></p><p> </p><p>In addition, NHS England, with the Health and Social Care Information Centre publishes an innovation scorecard which represents the rate of uptake and utility of medicines in both primary and secondary care, on a regular basis. This publication sets out levels of uptake and utility for National Institute for Health and Care Excellence appraised medicines and technologies, and evidence suggests that steady growth is being achieved and the most recent information is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/searchcatalogue?productid=15598&amp;q=innovation+scorecard&amp;sort=Relevance&amp;size=10&amp;page=1#top" target="_blank">www.hscic.gov.uk/searchcatalogue?productid=15598&amp;q=innovation+scorecard&amp;sort=Relevance&amp;size=10&amp;page=1#top</a></p><p> </p><p><strong> </strong></p><p> </p><p>Earlier this year, NHS England also undertook an extensive consultation to ‘refresh’ the Innovation Health and Wealth policy framework and we understand that recommendations from this will be included in NHS England's five year Forward Look.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 23/10/2014 16:35:13 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

92086

registered interest
date	26/09/2014
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Work Programme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 3 September 2014 to Question 207491, whether second attachment fees will be paid for people transferred from Newcastle College to new providers; and whether the cost of those fees will be borne by his Department.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	209437
answer	answer is ministerial correction date of answer 15/10/2014 answer text <p /> <p>Second “Attachment Fees” will not be paid for participants transferred to the new provider in CPA18. However, to ensure that existing Work Programme participants transferring to this new contract are engaged and receive meaningful support swiftly, the overall funding for this procurement includes the option of a limited transfer fee.</p> answering member constituency Wirral West answering member printed Esther McVey question first answered 15/10/2014 10:58:53 answering member 4084 label Biography information for Esther McVey
tabling member	4056 label Biography information for Nic Dakin